AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Alphabet-Backed Isomorphic Labs’ $2.1 Billion Bet Reflects a New Phase for AI-Designed Medicines
A string of reports around Isomorphic Labs’ $2.1 billion fundraise show how quickly AI drug discovery has become one of biotech’s hottest investment narratives. The round positions the company to push beyond discovery hype and into a more industrial model of therapeutic design.
J&J’s AI Interest Signals Drug Development Is Shifting From Experiment to Strategy
A RAPS roundup suggests Johnson & Johnson is exploring AI as a lever to cut drug development timelines, reflecting a broader pharma trend toward operationalizing AI. The article also notes improving UK biotech investment conditions, hinting at a more active market backdrop.
Anthropic’s $400M bet on Coefficient Bio signals a new phase in AI drug discovery
Anthropic’s reported $400 million investment in Coefficient Bio points to a major convergence between frontier AI labs and biotech. Rather than remaining tool suppliers, AI companies are increasingly trying to shape the core economics of drug discovery itself.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.